🔗 Visit the ClinicalTrials.gov page for NCT00110019
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Systematic review of medical treatment in melanoma: current status and future prospects. | Oncologist | 2011 | 2.89 |
| 2 | Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. | Angiogenesis | 2014 | 2.07 |
| 3 | Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma. | J Clin Oncol | 2012 | 1.09 |
| 4 | Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials. | Oncotarget | 2015 | 0.81 |
| 5 | The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents. | Bioorg Med Chem | 2014 | 0.80 |